Data on cost-effectiveness of LungLB® | 27-Feb-2023 | 07:00 | RNS |
Preliminary results for year ended 31 Dec 2022 | 20-Feb-2023 | 07:00 | RNS |
Notice of Results | 08-Feb-2023 | 07:00 | RNS |
Holding(s) in Company | 07-Dec-2022 | 14:37 | RNS |
Final Pricing Determination | 30-Nov-2022 | 07:00 | RNS |
Total Voting Rights | 30-Nov-2022 | 07:00 | RNS |
Block Listing Six Monthly Return | 15-Nov-2022 | 07:00 | RNS |
Director share purchases | 03-Nov-2022 | 07:00 | RNS |
Half-year Report | 26-Sep-2022 | 07:00 | RNS |
Notice of Results | 09-Sep-2022 | 07:00 | RNS |
New York State approval for commercial testing | 02-Sep-2022 | 07:00 | RNS |
Block Listing Six Monthly Return | 16-May-2022 | 07:00 | RNS |
Result of AGM | 11-May-2022 | 15:17 | RNS |
Publication of AR and Accounts & Notice of AGM | 08-Apr-2022 | 07:00 | RNS |
Preliminary Results | 28-Mar-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 17.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 123.00 |
52 Week Low | 17.00 |
Volume | 0 |
Shares Issued | 25.49m |
Market Cap | £4.33m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research